Telbolife AM 80 Tablet is a fixed-dose combination medication designed to effectively manage high blood pressure (hypertension) in patients requiring dual therapy. It combines two antihypertensive agents: Telmisartan, an angiotensin II receptor blocker (ARB), and Amlodipine, a calcium channel blocker (CCB). Together, they provide a synergistic approach to lowering blood pressure, thereby reducing the risk of cardiovascular complications such as stroke, heart attack, and kidney damage.
Telmisartan works by inhibiting the action of angiotensin II, a chemical in the body that narrows blood vessels, leading to increased blood pressure. By blocking this chemical, Telmisartan allows blood vessels to relax and widen, improving blood flow and reducing pressure on the heart.
Amlodipine, on the other hand, relaxes the smooth muscles in the walls of blood vessels by blocking calcium influx. This vasodilation helps lower systemic vascular resistance and enhances oxygen delivery to the heart, further supporting blood pressure control.
The combination of these two agents ensures better adherence, enhanced efficacy, and minimized fluctuations in blood pressure throughout the day. Telbolife AM 80 is particularly useful for patients who do not achieve adequate blood pressure control with monotherapy alone.
This tablet is generally taken once daily, with or without food, and should be used consistently at the same time each day for optimal effect. It is important for patients to maintain a healthy lifestyle, including a low-salt diet, regular physical activity, and stress management, in conjunction with pharmacological treatment.
Telbolife AM 80 is manufactured under high-quality standards to ensure safety, purity, and consistent therapeutic action, making it a reliable choice in the long-term management of hypertension.